Boswellia
14 benefits mapped to clinical evidence across supplements.
Dose per serving from products
90 products in our catalogue print how much Boswellia a serving holds.
Most common: 50 mg to 100 mg and 100 mg to 250 mg, 23% of 90 products each.
| Dose per serving | Products |
|---|---|
| 25 mg or less | 5 |
| 25 mg to 50 mg | 9 |
| 50 mg to 100 mg | 21 |
| 100 mg to 250 mg | 21 |
| 250 mg to 500 mg | 17 |
| 500 mg to 1 g | 13 |
| over 1 g | 4 |
Dose per serving from research
29 study groups in 24 studies say how much Boswellia participants took a day.
These are the doses the studies gave. They are not a recommendation.
Most common: 500 mg to 1 g, 34% of 29 study groups.
| Daily dose | Study groups |
|---|---|
| 50 mg or less | 1 |
| 50 mg to 100 mg | 6 |
| 100 mg to 250 mg | 4 |
| 250 mg to 500 mg | 6 |
| 500 mg to 1 g | 10 |
| 1 g to 2.5 g | 0 |
| 2.5 g to 5 g | 2 |
Commonly used together
11 of 29 study groups took Boswellia with something else. Shown: what 3 or more different studies gave.
What was given together, not what works together.
| Taken with | Study groups |
|---|---|
| Curcumin | 3 |
Benefit Evidence
Research sources
Joint comfort (20)
- The effect of turmeric-Boswellia formulation (Rhuleave-K) in posture-related low back soreness and discomfort: A randomized double blinded placebo controlled trial
PubMed ID: 39973246
Turmeric–Boswellia combination produced rapid, large reductions in posture‑related low back pain in randomized trial (combo product).
- Effect of a combination of C. longa and B. serrata extracts on hand osteoarthritis. Results of a double-blind, randomized, placebo-controlled, multicenter trial
PubMed ID: 40554037
Turmeric–Boswellia modestly reduced hand OA pain vs placebo (statistically significant but modest effect; combo product).
- Efficacy and tolerability of Boswellia serrata extract in treatment of osteoarthritis of knee--a randomized double blind placebo controlled trial
PubMed ID: 12622457
Randomized crossover showed Boswellia extract reduced knee pain and improved function — solid direct evidence.
- A double blind, randomized, placebo controlled study of the efficacy and safety of 5-Loxin for treatment of osteoarthritis of the knee
PubMed ID: 18667054
5‑Loxin (AKBA‑enriched Boswellia) produced large, dose‑dependent reductions in pain and function in knee OA — strong direct support.
- Comparative efficacy and tolerability of 5-Loxin and AflapinAgainst osteoarthritis of the knee: a double blind, randomized, placebo controlled clinical study
PubMed ID: 21060724
Aflapin (AKBA‑enriched Boswellia) gave large, rapid improvements in OA pain/function vs placebo — strong direct evidence.
- A double blind, randomized, placebo controlled clinical study evaluates the early efficacy of aflapin in subjects with osteoarthritis of knee
PubMed ID: 22022214
Aflapin trial showing fast and meaningful pain/function relief in knee OA supports joint comfort strongly.
- Ayurvedic medicine offers a good alternative to glucosamine and celecoxib in the treatment of symptomatic knee osteoarthritis: a randomized, double-blind, controlled equivalence drug trial
PubMed ID: 23365148
Large trial: Ayurvedic formulations including Boswellia were equivalent to glucosamine/celecoxib for knee OA — supports joint symptom benefit.
- Clinical evaluation of a formulation containing Curcuma longa and Boswellia serrata extracts in the management of knee osteoarthritis
PubMed ID: 24002213
Curcuma+Boswellia formulation outperformed low‑dose celecoxib in small knee OA trial — combined product, but clinically relevant joint benefit.
- Clinical comparison of oral administration and viscosupplementation of hyaluronic acid (HA) in early knee osteoarthritis
PubMed ID: 27681813
Oral HA + Boswellia improved pain and knee scores in early knee OA (oral multi-ingredient intervention).
- Evaluation of the effect of Elaeagnus angustifolia alone and combined with Boswellia thurifera compared with ibuprofen in patients with knee osteoarthritis: a randomized double-blind controlled clinical trial
PubMed ID: 28349271
Elaeagnus with Boswellia relieved knee OA pain/function comparably to ibuprofen over 4 weeks (combination product evidence).
- Efficacy and safety of curcumin and its combination with boswellic acid in osteoarthritis: a comparative, randomized, double-blind, placebo-controlled study
PubMed ID: 29316908
Large RCT: curcumin+boswellic acids significantly reduced knee OA pain and improved function vs placebo over 12 weeks.
- A Placebo-Controlled Double-Blind Study Demonstrates the Clinical Efficacy of a Novel Herbal Formulation for Relieving Joint Discomfort in Human Subjects with Osteoarthritis of Knee
PubMed ID: 29708818
90-day RCT of a Boswellia-containing herbal formula showed significant pain relief and improved physical function in knee OA.
- A pilot, randomized, double-blind, placebo-controlled trial to assess the safety and efficacy of a novel Boswellia serrata extract in the management of osteoarthritis of the knee
PubMed ID: 30838706
Randomized double-blind 120-day Boswellia extract trial improved WOMAC, VAS pain and lowered hs-CRP vs placebo.
- Efficacy and Safety of Aflapin®, a Novel Boswellia Serrata Extract, in the Treatment of Osteoarthritis of the Knee: A Short-Term 30-Day Randomized, Double-Blind, Placebo-Controlled Clinical Study
PubMed ID: 35512759
Standardized Boswellia (Aflapin) produced rapid, large reductions in VAS/WOMAC and biomarkers in knee OA within 30 days.
- [Comparative efficacy of a combination of undenatured type II collagen, Boswellic acids, methylsulfonylmethane, vitamins C and D(3) and a combination of chondroitin sulfate and glucosamine hydrochloride in the treatment of primary osteoarthritis of the knee joint]
PubMed ID: 38785054
Artneo (boswellic‑containing) produced greater stiffness decrease vs glucosamine+chondroitin in randomized trial.
- Efficacy of Boswellia serrata Extract and/or an Omega-3-Based Product for Improving Pain and Function in People Older Than 40 Years with Persistent Knee Pain: A Randomized Double-Blind Controlled Clinical Trial
PubMed ID: 37686880
Randomized trial showed boswellia (alone/with omega‑3) improved knee pain and WOMAC scores (boswellia contributed though some combination confounding).
- Evaluation of the effectiveness of topical oily solution containing frankincense extract in the treatment of knee osteoarthritis: a randomized, double-blind, placebo-controlled clinical trial
PubMed ID: 36869332
Topical frankincense significantly reduced knee OA pain and WOMAC vs placebo (randomized double‑blind).
- A Standardized Boswellia serrata Extract Improves Knee Joint Function and Cartilage Morphology in Human Volunteers with Mild to Moderate Osteoarthritis in a Randomized Placebo-Controlled Study
PubMed ID: 39700461
Aflapin® (standardized Boswellia extract) produced clear, randomized placebo‑controlled improvements in knee pain and function with supportive MRI cartilage changes.
- Investigating the Additive Effects of Loxacon(®) Food Supplement Capsules in Patients with Knee Osteoarthritis. A Multicenter, Randomized, Double-Blind, Controlled, Crossover, Follow-Up, Three-Arm Study
PubMed ID: 39446666
Boswellia‑containing nutraceutical plus physical therapy improved knee OA function and QoL vs therapy alone (multi‑ingredient product).
- Efficacy and Safety of Boswellia serrata and Apium graveolens L. Extract Against Knee Osteoarthritis and Cartilage Degeneration: A Randomized, Double-blind, Multicenter, Placebo-Controlled Clinical Trial
PubMed ID: 39875757
90‑day randomized trial of Boswellia‑containing nutraceutical produced very large reductions in WOMAC pain/stiffness/function and robust biomarker changes.
Inflammation (15)
- Functional improvement and immune-inflammatory cytokines profile of ischaemic stroke patients after treatment with boswellic acids: a randomized, double-blind, placebo-controlled, pilot trial
PubMed ID: 31407195
Boswellic acids after ischemic stroke lowered TNF-α and IL-6 and improved NIHSS, indicating anti-inflammatory and clinical benefits.
- Efficacy and Safety of Aflapin®, a Novel Boswellia Serrata Extract, in the Treatment of Osteoarthritis of the Knee: A Short-Term 30-Day Randomized, Double-Blind, Placebo-Controlled Clinical Study
PubMed ID: 35512759
Standardized Boswellia (Aflapin) reduced TNF-α, hsCRP, MMP-3 and improved OA symptoms within 30 days (strong anti-inflammatory signal).
- Inflawell(®) improves neutrophil-to-lymphocyte ratio and shortens hospitalization in patients with moderate COVID-19, in a randomized double-blind placebo-controlled clinical trial
PubMed ID: 35201518
Boswellia adjunct reduced IL-6, TNF-α and NLR and shortened hospitalization in moderate COVID-19 (clear anti-inflammatory/immunologic effects).
- Evaluation of the effectiveness of topical oily solution containing frankincense extract in the treatment of knee osteoarthritis: a randomized, double-blind, placebo-controlled clinical trial
PubMed ID: 36869332
Topical frankincense decreased local pain and WOMAC scores in knee OA, consistent with local anti‑inflammatory/analgesic action.
- A Standardized Boswellia serrata Extract Improves Knee Joint Function and Cartilage Morphology in Human Volunteers with Mild to Moderate Osteoarthritis in a Randomized Placebo-Controlled Study
PubMed ID: 39700461
Aflapin® reduced synovitis area (MRI) and improved pain/function, consistent with anti‑inflammatory joint effects in an RCT.
- Efficacy and safety evaluation of Boswellia serrata and Curcuma longa extract combination in the management of chronic lower back pain: A randomised, double-blind, placebo-controlled clinical study
PubMed ID: 39700654
Boswellia+curcumin RCT showed reductions in TNF‑α, IL‑6 and hsCRP alongside pain/disability improvements (combo product).
- Efficacy and Safety of Boswellia serrata and Apium graveolens L. Extract Against Knee Osteoarthritis and Cartilage Degeneration: A Randomized, Double-blind, Multicenter, Placebo-Controlled Clinical Trial
PubMed ID: 39875757
Large randomized trial demonstrated very large reductions in IL‑6, IL‑1, TNF‑α and hsCRP and concurrent symptomatic benefit.
- Effects of Boswellia serrata gum resin in patients with bronchial asthma: results of a double-blind, placebo-controlled, 6-week clinical study
PubMed ID: 9810030
Boswellia gum resin reduced eosinophil counts and improved asthma parameters — supports anti‑inflammatory respiratory effects.
- Effects of gum resin of Boswellia serrata in patients with chronic colitis
PubMed ID: 11488449
Boswellia resin improved colitis remission rates vs sulfasalazine indicating anti‑inflammatory action in the gut.
- [Therapy of active Crohn disease with Boswellia serrata extract H 15]
PubMed ID: 11215357
Boswellia non‑inferior to mesalazine in active Crohn's suggests significant anti‑inflammatory/intestinal effect.
- A double blind, randomized, placebo controlled study of the efficacy and safety of 5-Loxin for treatment of osteoarthritis of the knee
PubMed ID: 18667054
5‑Loxin reduced synovial MMP‑3 and produced large clinical improvements in OA — strong anti‑inflammatory evidence.
- Comparative efficacy and tolerability of 5-Loxin and AflapinAgainst osteoarthritis of the knee: a double blind, randomized, placebo controlled clinical study
PubMed ID: 21060724
Aflapin gave rapid symptom and function improvements consistent with anti‑inflammatory action; AKBA enrichment supports mechanism.
- Boswellia serrata acts on cerebral edema in patients irradiated for brain tumors: a prospective, randomized, placebo-controlled, double-blind pilot trial
PubMed ID: 21287538
Pilot RCT showed MRI‑measured cerebral edema reduction after Boswellia — objective anti‑edema/anti‑inflammatory effect.
- Efficacy and safety of curcumin and its combination with boswellic acid in osteoarthritis: a comparative, randomized, double-blind, placebo-controlled study
PubMed ID: 29316908
Curcumin+boswellic acid combination reduced pain/function and likely inflammatory activity in knee OA (clinical anti-inflammatory benefit).
- A pilot, randomized, double-blind, placebo-controlled trial to assess the safety and efficacy of a novel Boswellia serrata extract in the management of osteoarthritis of the knee
PubMed ID: 30838706
120-day Boswellia extract decreased hs-CRP and improved pain/function in knee OA (robust anti-inflammatory/clinical effect).
Joint mobility (14)
- A double blind, randomized, placebo controlled clinical study evaluates the early efficacy of aflapin in subjects with osteoarthritis of knee
PubMed ID: 22022214
Aflapin produced rapid improvements in function and Lequesne index — early gains in movement ease.
- Efficacy and tolerability of Boswellia serrata extract in treatment of osteoarthritis of knee--a randomized double blind placebo controlled trial
PubMed ID: 12622457
Crossover trial reported increased knee flexion and walking distance with Boswellia — direct evidence for easier movement.
- A double blind, randomized, placebo controlled study of the efficacy and safety of 5-Loxin for treatment of osteoarthritis of the knee
PubMed ID: 18667054
5‑Loxin markedly improved physical function in OA patients (WOMAC function/Lequesne) — supports easier movement.
- Comparative efficacy and tolerability of 5-Loxin and AflapinAgainst osteoarthritis of the knee: a double blind, randomized, placebo controlled clinical study
PubMed ID: 21060724
Aflapin yielded large improvements in WOMAC function and VAS enabling easier movement.
- Efficacy and safety of curcumin and its combination with boswellic acid in osteoarthritis: a comparative, randomized, double-blind, placebo-controlled study
PubMed ID: 29316908
Curcumin+boswellic acid improved objective physical performance (chair-stand) and WOMAC function in knee OA RCT.
- A Placebo-Controlled Double-Blind Study Demonstrates the Clinical Efficacy of a Novel Herbal Formulation for Relieving Joint Discomfort in Human Subjects with Osteoarthritis of Knee
PubMed ID: 29708818
Boswellia-containing formula reduced joint pain and improved function over 90 days (functional gains).
- A pilot, randomized, double-blind, placebo-controlled trial to assess the safety and efficacy of a novel Boswellia serrata extract in the management of osteoarthritis of the knee
PubMed ID: 30838706
120-day Boswellia extract improved WOMAC and VAS and reduced hs-CRP, correlating with improved movement/function.
- Efficacy and Safety of Aflapin®, a Novel Boswellia Serrata Extract, in the Treatment of Osteoarthritis of the Knee: A Short-Term 30-Day Randomized, Double-Blind, Placebo-Controlled Clinical Study
PubMed ID: 35512759
Aflapin Boswellia produced rapid and large improvements in WOMAC/stiffness/function supporting easier movement.
- [Comparative efficacy of a combination of undenatured type II collagen, Boswellic acids, methylsulfonylmethane, vitamins C and D(3) and a combination of chondroitin sulfate and glucosamine hydrochloride in the treatment of primary osteoarthritis of the knee joint]
PubMed ID: 38785054
Boswellia‑containing product yielded similar WOMAC/function improvements and better stiffness outcomes vs glucosamine+chondroitin.
- Efficacy of Boswellia serrata Extract and/or an Omega-3-Based Product for Improving Pain and Function in People Older Than 40 Years with Persistent Knee Pain: A Randomized Double-Blind Controlled Clinical Trial
PubMed ID: 37686880
Boswellia (especially combined with omega‑3) improved mobility measures (TUG) and WOMAC function in an RCT.
- Evaluation of the effectiveness of topical oily solution containing frankincense extract in the treatment of knee osteoarthritis: a randomized, double-blind, placebo-controlled clinical trial
PubMed ID: 36869332
Topical frankincense reduced pain and WOMAC scores, translating to functional/mobility benefit in knee OA.
- A Standardized Boswellia serrata Extract Improves Knee Joint Function and Cartilage Morphology in Human Volunteers with Mild to Moderate Osteoarthritis in a Randomized Placebo-Controlled Study
PubMed ID: 39700461
Aflapin® improved pain and function and showed MRI cartilage benefits over 6 months (placebo‑controlled), supporting easier movement.
- Investigating the Additive Effects of Loxacon(®) Food Supplement Capsules in Patients with Knee Osteoarthritis. A Multicenter, Randomized, Double-Blind, Controlled, Crossover, Follow-Up, Three-Arm Study
PubMed ID: 39446666
Nutraceutical added to PT improved function and ROM vs PT alone (multi‑ingredient product).
- Efficacy and Safety of Boswellia serrata and Apium graveolens L. Extract Against Knee Osteoarthritis and Cartilage Degeneration: A Randomized, Double-blind, Multicenter, Placebo-Controlled Clinical Trial
PubMed ID: 39875757
Significant decreases in cartilage breakdown markers (CTX‑II, COMP, MMP‑3) and increases in synthesis markers (PIIANP/PIICP) indicate strong support for joint structural resilience.
Illness recovery (8)
- Randomized controlled trial of bromelain and alpha-lipoic acid in breast conservative surgery
PubMed ID: 39929877
Large perioperative RCT of Boswellia‑containing nutraceutical showed marked reductions in post‑surgical oedema/seroma — supports faster local recovery.
- Fast pain relief in exercise-induced acute musculoskeletal pain by turmeric-boswellia formulation: A randomized placebo-controlled double-blinded multicentre study
PubMed ID: 36107505
Single 1000 mg turmeric–Boswellia dose produced fast, substantial pain relief after exercise-induced injury (rapid symptomatic recovery).
- A Nutraceutical Combination of Bromelain and Boswellia Serrata Casperome® in Siben®: Effects on the Postoperative Course of Inguinal Hernioplasty with Mesh at One Year Follow up. A Randomized Multicentric Study
PubMed ID: 38918956
Bromelain+Boswellia post‑inguinal hernia nutraceutical reduced early postoperative pain and sped return to activities in a multicenter randomized trial (combo product).
- Positive Effects of a Lecithin-Based Delivery Form of Boswellia serrata Extract in Acute Diarrhea of Adult Subjects
PubMed ID: 35565826
Boswellia phytosome shortened acute diarrhea recovery by ~1.4 days vs placebo (primary endpoint of RCT).
- Functional improvement and immune-inflammatory cytokines profile of ischaemic stroke patients after treatment with boswellic acids: a randomized, double-blind, placebo-controlled, pilot trial
PubMed ID: 31407195
Adding boswellic acids after ischemic stroke improved neurological scores and lowered inflammatory markers over one month (clinical recovery signal).
- Inflawell(®) improves neutrophil-to-lymphocyte ratio and shortens hospitalization in patients with moderate COVID-19, in a randomized double-blind placebo-controlled clinical trial
PubMed ID: 35201518
Boswellia syrup shortened hospital stay by ~1 day and improved inflammatory markers in moderate COVID-19 (faster clinical recovery).
- Efficacy and Safety of Boswellia serrata and Apium graveolens L. Extract Against Knee Osteoarthritis and Cartilage Degeneration: A Randomized, Double-blind, Multicenter, Placebo-Controlled Clinical Trial
PubMed ID: 39875757
90‑day knee OA trial showed large symptomatic and biomarker improvements suggesting accelerated joint recovery/repair (randomized trial).
- The effect of turmeric-Boswellia formulation (Rhuleave-K) in posture-related low back soreness and discomfort: A randomized double blinded placebo controlled trial
PubMed ID: 39973246
Turmeric–Boswellia gave rapid and large short‑term pain/disability reductions in low back pain trial, implying faster symptomatic recovery (combo product).
Wellbeing (8)
- Efficacy and Safety of Boswellia serrata and Apium graveolens L. Extract Against Knee Osteoarthritis and Cartilage Degeneration: A Randomized, Double-blind, Multicenter, Placebo-Controlled Clinical Trial
PubMed ID: 39875757
Large symptomatic and biomarker improvements in knee OA trial likely translate to meaningful overall wellbeing gains.
- Efficacy of Boswellia serrata L. and Cyperus scariosus L. plus pelvic floor muscle training in stress incontinence in women of reproductive age
PubMed ID: 25225151
Combination with Boswellia plus pelvic-floor training reduced urinary loss more than placebo plus training, improving daily functioning/QoL.
- The effect of frankincense (Boswellia serrata, oleoresin) and ginger (Zingiber officinale, rhizoma) on heavy menstrual bleeding: A randomized, placebo-controlled, clinical trial
PubMed ID: 30670277
Frankincense during menses reduced bleeding days and improved quality‑of‑life vs placebo (direct QoL improvement).
- L-Methionine associated with Hibiscus sabdariffa and Boswellia serrata extracts are not inferior to antibiotic treatment for symptoms relief in patients affected by recurrent uncomplicated urinary tract infections: Focus on antibiotic-sparing approach
PubMed ID: 29974725
Phytotherapy containing Boswellia relieved recurrent UTI symptoms and improved QoL comparably to antibiotics.
- A pilot, randomized, double-blind, placebo-controlled trial to assess the safety and efficacy of a novel Boswellia serrata extract in the management of osteoarthritis of the knee
PubMed ID: 30838706
Boswellia extract improved pain/function in knee OA and lowered hs-CRP, likely improving overall wellbeing.
- Efficacy and Safety of Aflapin®, a Novel Boswellia Serrata Extract, in the Treatment of Osteoarthritis of the Knee: A Short-Term 30-Day Randomized, Double-Blind, Placebo-Controlled Clinical Study
PubMed ID: 35512759
Standardized Boswellia produced rapid large symptomatic and biomarker improvements in knee OA, increasing patient wellbeing.
- Efficacy of frankincense-based herbal product in urinary incontinence: A randomized, double-blind, placebo- and active-controlled clinical trial
PubMed ID: 36442480
Frankincense-based oral product reduced leakage frequency and improved QoL in mixed urinary incontinence (trial vs placebo/solifenacin).
- A Nutraceutical Combination of Bromelain and Boswellia Serrata Casperome® in Siben®: Effects on the Postoperative Course of Inguinal Hernioplasty with Mesh at One Year Follow up. A Randomized Multicentric Study
PubMed ID: 38918956
Supplement produced faster recovery and better SF‑36 QoL after hernia repair (multicenter RCT, combo product).
Relaxation (6)
- Fast pain relief in exercise-induced acute musculoskeletal pain by turmeric-boswellia formulation: A randomized placebo-controlled double-blinded multicentre study
PubMed ID: 36107505
Turmeric–Boswellia produced rapid meaningful pain relief after exercise injury (strong soothing/analgesic signal).
- The effect of frankincense (Boswellia serrata, oleoresin) and ginger (Zingiber officinale, rhizoma) on heavy menstrual bleeding: A randomized, placebo-controlled, clinical trial
PubMed ID: 30670277
Frankincense during menses reduced bleeding and improved QoL (soothing symptomatic benefit).
- The Efficacy of Kundur (Boswellia serrata Roxb. Ex Colebr.) in Vulvovaginal Candidiasis: A Randomized Control Trial
PubMed ID: 35751891
Vaginal Boswellia inserts significantly reduced itching and discharge vs miconazole, providing clear symptomatic soothing benefit.
- Evaluation of the effectiveness of topical oily solution containing frankincense extract in the treatment of knee osteoarthritis: a randomized, double-blind, placebo-controlled clinical trial
PubMed ID: 36869332
Topical Boswellia oil produced clinically meaningful local pain relief and improved global assessment vs placebo in knee OA trial.
- A Nutraceutical Combination of Bromelain and Boswellia Serrata Casperome® in Siben®: Effects on the Postoperative Course of Inguinal Hernioplasty with Mesh at One Year Follow up. A Randomized Multicentric Study
PubMed ID: 38918956
Postoperative pain reductions with Boswellia‑containing nutraceutical indicate soothing analgesic effects (combo supplement).
- Positive Effects of a Lecithin-Based Delivery Form of Boswellia serrata Extract in Acute Diarrhea of Adult Subjects
PubMed ID: 35565826
Oral Boswellia reduced abdominal pain in acute diarrhea RCT, offering internal soothing of GI discomfort.
Pain relief (5)
- Efficacy of high-dissolution turmeric-sesame formulation for pain relief in adult subjects with acute musculoskeletal pain compared to acetaminophen: A randomized controlled study
PubMed ID: 32664057
Turmeric–Boswellia–sesame formulation relieved acute musculoskeletal pain comparably to acetaminophen (combination product evidence).
- Fast pain relief in exercise-induced acute musculoskeletal pain by turmeric-boswellia formulation: A randomized placebo-controlled double-blinded multicentre study
PubMed ID: 36107505
Turmeric–Boswellia single dose produced fast and substantial analgesia after exercise-induced acute musculoskeletal injury (muscle pain relief).
- Evaluation of the effectiveness of topical oily solution containing frankincense extract in the treatment of knee osteoarthritis: a randomized, double-blind, placebo-controlled clinical trial
PubMed ID: 36869332
Topical frankincense reduced local pain in knee OA and may relieve muscular discomfort adjacent to joints.
- A Nutraceutical Combination of Bromelain and Boswellia Serrata Casperome® in Siben®: Effects on the Postoperative Course of Inguinal Hernioplasty with Mesh at One Year Follow up. A Randomized Multicentric Study
PubMed ID: 38918956
Postoperative trial reported reduced pain and faster functional recovery with a Boswellia‑containing nutraceutical (multicenter RCT, combo).
- The effect of turmeric-Boswellia formulation (Rhuleave-K) in posture-related low back soreness and discomfort: A randomized double blinded placebo controlled trial
PubMed ID: 39973246
Turmeric–Boswellia gave rapid, large reductions in posture‑related low back pain and disability, supporting relief of muscular/axial pain (combo product).
Digestive support (5)
- [Therapy of active Crohn disease with Boswellia serrata extract H 15]
PubMed ID: 11215357
Boswellia (H15) non‑inferior to mesalazine for active Crohn's — direct, clinically relevant digestive benefit.
- Beneficial Effects on Abdominal Bloating with an Innovative Food-Grade Formulation of Curcuma longa and Boswellia serrata Extracts in Subjects with Irritable Bowel Syndrome and Small Bowel Dysbiosis
PubMed ID: 35276778
Curcumin–Boswellia combo produced large reductions in bloating and abdominal pain (RCT), but effect cannot be attributed to Boswellia alone.
- Positive Effects of a Lecithin-Based Delivery Form of Boswellia serrata Extract in Acute Diarrhea of Adult Subjects
PubMed ID: 35565826
Single‑ingredient lecithin Boswellia shortened acute diarrhea, reduced stool frequency and abdominal pain in randomized double‑blind trial.
- Oral administration of a lecithin-based delivery form of boswellic acids (Casperome®) for the prevention of symptoms of irritable bowel syndrome: a randomized clinical study
PubMed ID: 30676012
Boswellia lecithin formulation significantly reduced IBS symptom scores and need for rescue meds over 6 months.
- Effects of gum resin of Boswellia serrata in patients with chronic colitis
PubMed ID: 11488449
Small trial showed higher remission in chronic colitis with Boswellia gum resin vs sulfasalazine — direct digestive benefit.
Healthy aging (5)
- A Standardized Boswellia serrata Extract Improves Knee Joint Function and Cartilage Morphology in Human Volunteers with Mild to Moderate Osteoarthritis in a Randomized Placebo-Controlled Study
PubMed ID: 39700461
Aflapin® improved MRI cartilage morphology over 6 months, implying potential structural/aging‑related joint benefit.
- Efficacy and Safety of Boswellia serrata and Apium graveolens L. Extract Against Knee Osteoarthritis and Cartilage Degeneration: A Randomized, Double-blind, Multicenter, Placebo-Controlled Clinical Trial
PubMed ID: 39875757
Large improvements in cartilage turnover biomarkers (↓CTX‑II, ↑PIIANP/PIICP) in knee OA suggest support for joint structural health relevant to healthy aging.
- The effect of tablet containing Boswellia serrata and Melisa officinalis extract on older adults' memory: A randomized controlled trial
PubMed ID: 29306113
Cognitive test improvements in older adults with Boswellia+Melissa may support cognitive aspects of healthy aging.
- Silymarin, Olibanum, and Nettle, A Mixed Herbal Formulation in the Treatment of Type II Diabetes: A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial
PubMed ID: 29228792
Three-month herbal mix including Boswellia produced clinically meaningful HbA1c and fasting glucose reductions in T2DM (metabolic aging risk reduction).
- Curcumin and Boswellia serrata Modulate the Glyco-Oxidative Status and Lipo-Oxidation in Master Athletes
PubMed ID: 27879642
Curcumin+BSE markedly lowered AGEs in master athletes—AGE reduction is relevant to healthy aging biology.
Mood balance (2)
- The effect of tablet containing Boswellia serrata and Melisa officinalis extract on older adults' memory: A randomized controlled trial
PubMed ID: 29306113
Boswellia + Melissa tablets improved several memory test scores in older adults (cognitive/mood‑related benefit region).
- Boswellia serrata extract shows cognitive benefits in a double-blind, randomized, placebo-controlled pilot clinical trial in individuals who suffered traumatic brain injury
PubMed ID: 35385330
Boswellia-based supplement improved objective cognitive test scores months–years after TBI (may support mood/cognitive balance).
Immune support (2)
- L-Methionine associated with Hibiscus sabdariffa and Boswellia serrata extracts are not inferior to antibiotic treatment for symptoms relief in patients affected by recurrent uncomplicated urinary tract infections: Focus on antibiotic-sparing approach
PubMed ID: 29974725
Phytotherapy containing Boswellia provided symptom relief in recurrent UTI and improved QoL versus antibiotics (clinical immune/infection context).
- Inflawell(®) improves neutrophil-to-lymphocyte ratio and shortens hospitalization in patients with moderate COVID-19, in a randomized double-blind placebo-controlled clinical trial
PubMed ID: 35201518
Boswellia extract adjunct in moderate COVID-19 shortened hospital stay and lowered IL-6/TNF-α and NLR (immunomodulatory signal).
Antioxidant (2)
- Oral administration of a lecithin-based delivery form of boswellic acids (Casperome®) for the prevention of symptoms of irritable bowel syndrome: a randomized clinical study
PubMed ID: 30676012
Boswellia lecithin formulation lowered oxidative stress markers vs symptomatic management in IBS patients.
- Curcumin and Boswellia serrata Modulate the Glyco-Oxidative Status and Lipo-Oxidation in Master Athletes
PubMed ID: 27879642
Curcumin+Boswellia combo produced large reductions in AGEs and MDA (direct antioxidant/anti‑oxidative-stress outcomes).
Respiratory comfort (2)
- Functional study on Boswellia phytosome as complementary intervention in asthmatic patients
PubMed ID: 26502867
Curcumin+Boswellia supplement reduced needed inhalations in asthma patients when added to standard therapy (clinical breath/airway benefit).
- Effects of Boswellia serrata gum resin in patients with bronchial asthma: results of a double-blind, placebo-controlled, 6-week clinical study
PubMed ID: 9810030
Double‑blind placebo‑controlled study of Boswellia gum resin alone in bronchial asthma produced marked symptom and lung function improvements — strong, direct evidence for clearer breathing.
Skin health (1)
- Episiotomy wound healing by Commiphora myrrha (Nees) Engl. and Boswellia carteri Birdw. in primiparous women: A randomized controlled trial
PubMed ID: 32971163
Topical frankincense shortened episiotomy wound healing time somewhat versus controls (wound/skin healing signal).
Similar by evidence
Supplements the same benefits carry qualifying findings for — a fact about the evidence graph, not a recommendation to swap.
Products with Boswellia
Search all210 products whose verified label declares Boswellia — not every bottle that mentions it in a title.
Being studied right now
Recruiting clinical trials registered on ClinicalTrials.gov. A trial in progress has no result yet — this is what the field is asking, not what it found.